| MyD88 Protein | |
|---|---|
| Gene | MYD88 |
| UniProt | Q99836 |
| PDB | 2Z5V, 3MOP, 4DOM |
| Mol. Weight | 33 kDa |
| Localization | Cytoplasm |
| Family | MyD88 adaptor-like (Mal) family |
| Diseases | Alzheimer's Disease, Parkinson's Disease, ALS |
Myd88 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MyD88 (Myeloid Differentiation Primary Response 88) is encoded by the MYD88 gene. It belongs to the MyD88 adaptor-like (Mal) family and has a molecular weight of approximately 33 kDa^1. This protein is localized to Cytoplasm and plays a significant role in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, ALS.
MyD88 (Myeloid differentiation primary response 88) is a critical adaptor protein in Toll-like receptor (TLR) and IL-1R signaling pathways. MyD88 contains an N-terminal death domain that interacts with TLRs and IL-1R, and a C-terminal Toll/IL-1 receptor domain. Upon receptor activation, MyD88 recruits IRAK kinases, leading to downstream NF-κB and MAPK activation. MyD88 is essential for innate immune responses in the brain, where it mediates microglial activation by TLR ligands and pro-inflammatory cytokines. In neurodegenerative diseases, MyD88-dependent signaling contributes to chronic neuroinflammation. MyD88 deficiency in microglia reduces amyloid-β plaque burden and improves cognitive function in mouse models of Alzheimer's disease. MyD88 also plays roles in Parkinson's disease (α-synuclein-induced inflammation) and ALS. Targeting MyD88 signaling represents a therapeutic strategy for reducing harmful neuroinflammation.
The MyD88 protein has been characterized structurally through X-ray crystallography. Available PDB structures include: 2Z5V, 3MOP, 4DOM^2.
The protein's three-dimensional structure can also be explored via the AlphaFold Protein Structure Database.
Under physiological conditions, MyD88 performs essential functions in innate immunity. It is primarily found in Cytoplasm and contributes to normal cellular homeostasis, signaling, and immune function.
MyD88 is the central adaptor protein for most Toll-like receptors and IL-1 receptor family members:
Upon receptor activation:
MyD88 is implicated in the following neurodegenerative conditions:
Dysregulation of MyD88 contributes to neuronal damage through various mechanisms including chronic neuroinflammation, increased cytokine production, and glial activation.
MyD88 represents an important therapeutic target. Multiple drug development programs are exploring strategies to modulate its function:
The study of Myd88 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Akira S, Takeda K. (2004). Toll-like receptor signalling. Nat Rev Immunol. 4(7):499-511. DOI
Lin SC, et al. (2010). Crystal structure of the Toll-like receptor adaptor Mal. Nature. 465(7300):885-890. DOI
Kawai T, Akira S. (2010). The role of pattern-recognition receptors in innate immunity. Nat Rev Immunol. 10(6):351-365. DOI
Bsibsi M, et al. (2002). Expression of Toll-like receptors in astrocytes and microglia. Glia. 40(2):165-174. DOI
Okun E, et al. (2011). TLR signaling and neuronal.glial: Implications for Alzheimer's disease. J Neuroimmune Pharmacol. 6(2):175-186. DOI